Geno2pheno[coreceptor] 3 Geno2pheno[454] Geno2pheno[454] - PowerPoint PPT Presentation

Sep 07, 2022 •499 likes •623 views

geno2pheno [454] Coreceptor usage prediction with massively parallel sequencing Alexander Thielen 2 Geno2pheno[coreceptor] 3 Geno2pheno[454] Geno2pheno[454] fasta-format sff-, or fasta-format .g2p-file 4 454 website

geno2pheno [454] Coreceptor usage prediction with massively parallel sequencing Alexander Thielen
2 Geno2pheno[coreceptor]
3 Geno2pheno[454]
Geno2pheno[454] fasta-format sff-, or fasta-format .g2p-file 4
454 website http://g2p-454.bioinf.mpi- inf.mpg.de/storedResults.php?run=20100420/450935140 5
6 Results
7 Results
8 Results
9 Results
10 Results
Acknowledgments Max-Planck-Institute for Informatics, Germany André Altmann, Achim Büch, Thomas Lengauer University of Cologne, Germany Eva Heger, Saleta Sierra, Rolf Kaiser British Columbia Center for Excellence, Canada Luke C Swenson, Conan Woods, P. Richard Harrigan Institute of Immunology and Genetics, Kaiserslautern, Germany Martin Däumer, Rolf Klein, Bernhard Thiele 11

Recommend

Outline HIV coreceptors Importance of coreceptor usage Determination and prediction

Alexander Thielen geno2pheno [ CORECEPTOR ] Outline HIV coreceptors Importance of coreceptor usage Determination and prediction geno2pheno[coreceptor] Outlook of new features Summary Thielen, Alexander 26/04/2007 geno2pheno[coreceptor] 2

489 views • 16 slides

Genotypic analysis of coreceptor usage New developments and applications for geno2pheno [

Genotypic analysis of coreceptor usage New developments and applications for geno2pheno [ coreceptor ] Alexander Thielen Department of Computational Biology and Applied Algorithmics Max Planck Institute for Informatics D-66123 Saarbrcken

548 views • 26 slides

Update 2017 HIV-Grade Tools HIV-1 HIV-2 NNRTI -- NRTI NRTI PI PI

Josef Eberle Update 2017 HIV-Grade Tools HIV-1 HIV-2 NNRTI -- NRTI NRTI PI PI Fusion (gp41) -- InSTI InSTI [Coreceptor geno2pheno] [Coreceptor geno2pheno] HBV HCV with geno2pheno Pt with

329 views • 14 slides

Effects of Sequencing Errors on geno2pheno [coreceptor] Alejandro Pironti, Saleta Sierra, Rolf

Effects of Sequencing Errors on geno2pheno [coreceptor] Alejandro Pironti, Saleta Sierra, Rolf Kaiser, Thomas Lengauer and Nico Pfeifer Computational Biology and Applied Algorithmics Max Planck Institute for Informatics April 18, 2013

271 views • 11 slides

Coreceptor Tropism of HIV-1 Development of a virus-free Assay HIV-1 Tropism Study

Update from the AREVIR-projects University of Cologne Institute of Virology Coreceptor Tropism of HIV-1 Development of a virus-free Assay HIV-1 Tropism Study Comparison of Trofile and Geno2pheno [coreceptor] Eva Heger Institute of

300 views • 13 slides

Geno2pheno[HCV] - Past, Present & Future Developments Bastian Beggel Max-Planck-Institute

Geno2pheno[HCV] - Past, Present & Future Developments Bastian Beggel Max-Planck-Institute for Informatics D-66123 Saarbrcken, Germany geno2pheno[HCV] geno2pheno[HCV] web-service for the analysis of HCV sequence data

1.01k views • 15 slides

geno2pheno[hbv] - A Web Service for HBV Drug Resistance Analysis Bastian Beggel

geno2pheno[hbv] - A Web Service for HBV Drug Resistance Analysis Bastian Beggel Max-Planck-Institute for Informatics D-66123 Saarbrcken, Germany geno2pheno[hbv] geno2pheno[hbv] web-service for the analysis of HBV sequences drug

408 views • 15 slides

CRF01_AE: Do we need a customized CCR5 antagonist treatment recommendation? Nico Pfeifer Max

CRF01_AE: Do we need a customized CCR5 antagonist treatment recommendation? Nico Pfeifer Max Planck Insitute for Informatics HIV coreceptor usage HIV coreceptor usage HIV coreceptor usage HIV coreceptor usage CRF01_AE update Recent

367 views • 15 slides

EucoHIV - The European coreceptor HIV-1 cohort study: outcomes of maraviroc use across Europe

EucoHIV - The European coreceptor HIV-1 cohort study: outcomes of maraviroc use across Europe Matthias Dring Max Planck Institute for Informatics May 2, 2016 Overview of the EucoHIV study Coreceptor usage: Follow for up to 48 weeks and

532 views • 15 slides

HCV AND HEPATITIS HCV epidemiology and treatment failure Arevir meeting, 04.05.2019 | Saleta

HCV AND HEPATITIS HCV epidemiology and treatment failure Arevir meeting, 04.05.2019 | Saleta Sierra Geno2pheno [HCV] Team Geno2pheno [HCV] USAGE Geno2pheno [HCV] USAGE PEPSI Study in numbers 2882 Patienten 4759 Proben 46 DAA-therapy

633 views • 26 slides

Hauke Walter Medizinisches Labor Stendal News ticker Changes in the scoring system Update

Hauke Walter Medizinisches Labor Stendal News ticker Changes in the scoring system Update the algorithms New drugs Other targets: HCV resistance tool is mediated via geno2pheno (like HIV coreceptor) HBV (HBs escape mutation

323 views • 9 slides

Interpretation tools for coreceptor usage Rolf Kaiser Institute of Virology University of

Interpretation tools for coreceptor usage Rolf Kaiser Institute of Virology University of Cologne Coreceptor Usage 2 Chemokinreceptors are used in vivo as coreceptors: CCR5 & CXCR4 CCR5 only (R5-Virus) CXCR4 only (X4-Virus)

964 views • 38 slides

HIV-1 coreceptor usage prediction without multiple alignments S ebastien Boisvert, M.Sc.

HIV-1 coreceptor usage prediction without multiple alignments S ebastien Boisvert, M.Sc. student, Universit e Laval www.graal.ift.ulaval.ca Directors: Jacques Corbeil and Mario Marchand 1 HIV HIV (human immunodeficiency virus) is the

1.1k views • 20 slides

A genotypic method for the identification of HIV-2 coreceptor usage Matthias Dring Max Planck

A genotypic method for the identification of HIV-2 coreceptor usage Matthias Dring Max Planck Institute for Informatics AREVIR meeting May 26, 2017 HIV-2 is prevalent in West Africa and Europe Ibe S, Sugiura W. Recombinant Forms of HIV-2.

619 views • 36 slides

European Clinical Data on HIV-1 Coreceptor Usage and Genotypic Identification of Tropism in HIV-2

European Clinical Data on HIV-1 Coreceptor Usage and Genotypic Identification of Tropism in HIV-2 Matthias Dring Max Planck Institute for Informatics May 8, 2015 Coreceptors are crucial for HIV-1 cell entry Delhalle et al, Int. J. Mol. Sci.

600 views • 17 slides

geno2pheno[ngs-freq]: a novel tool for drug resistance testing in the era of next- generation

geno2pheno[ngs-freq]: a novel tool for drug resistance testing in the era of next- generation sequencing Matthias Dring Max Planck Institute for Informatics AREVIR Meeting 2018 - New Strategies - May 9, 2018 Imagine the following patient

360 views • 15 slides

geno2pheno[hcv] Bastian Beggel and Sven-Eric Schelhorn May 2012 2 Hepatitis C Small,

geno2pheno[hcv] Bastian Beggel and Sven-Eric Schelhorn May 2012 2 Hepatitis C Small, enveloped flavivirus (ss+ RNA) 9.6 kb-long genome, 10 proteins Affects hepatocytes in human, chimp ~200 Million infected humans, most

299 views • 14 slides

Recommendations for determining HIV-1 coreceptor usage CCR5 antagonists proved their good efficacy

Recommendations for determining HIV-1 coreceptor usage CCR5 antagonists proved their good efficacy in ART-nave and ART-experienced HIV-patients harbouring CCR5-tropic virus only (Heera 2008, Hardy 2008). A rapid diagnostic should be available

190 views • 3 slides

V3 Loop Sequence Space Analysis Kasia Bo ek bozek@mpi-inf.mpg.de MPI Saarbrcken AREVIR

V3 Loop Sequence Space Analysis Kasia Bo ek bozek@mpi-inf.mpg.de MPI Saarbrcken AREVIR meeting, Bonn 11.04.2008 V3 loop highly variable genome sequence related to coreceptor usage CCR5-CXCR4 coreceptor switch related to rapid disease

812 views • 34 slides

The impact of APOBEC on the tropism of HIV Eva Heger AREVIR 09.05.2015 Eva Heger - The

The impact of APOBEC on the tropism of HIV Eva Heger AREVIR 09.05.2015 Eva Heger - The impact of APOBEC on the tropism of HIV - Tropism Coreceptor usage of HIV attachment to CD4 Coreceptor binding fusion gp41 gp120 V3 loop

783 views • 35 slides

Algorithm and clinical validation M. Obermeier 4/2007 Interpretation-systems Free available:

Algorithm and clinical validation M. Obermeier 4/2007 Interpretation-systems Free available: Rule based: ANRS HIVdb REGA Truly bioinformatics based: geno2pheno [resistance] geno2pheno [THEO] M. Obermeier 4/2007

463 views • 32 slides

New developments for geno2pheno Prof. Nico Pfeifer Uni Tbingen Excellence cluster: Machine

New developments for geno2pheno Prof. Nico Pfeifer Uni Tbingen Excellence cluster: Machine Learning: New Perspectives for Science (Tbingen) 3 Biomedical Data Science Biomedical Data Science Coding skills are necessary for working

254 views • 24 slides

New graphical user interface for geno2pheno resistance Joachim Bch Max Planck Institute for

New graphical user interface for geno2pheno resistance Joachim Bch Max Planck Institute for Informatics Saarbrcken, Germany GUI for g2p_resistance INRENE Joachim Bch, 2006 GUI for g2p_resistance INRENE Joachim Bch, 2006 GUI for

285 views • 7 slides

Overview Introduction to HIV therapy Arevir geno2pheno Patient consent and patient identifiers

Arevir: a secure platform for designing personalized antiretroviral therapies against HIV Kirsten Roomp Computational Biology and Applied Algorithmics Max Planck Institute for Informatics 66123 Saarbrcken Germany Overview Introduction to

572 views • 29 slides